Amrize Ltd $AMRZ Stock Purchased by Kestra Advisory Services LLC

Kestra Advisory Services LLC lifted its stake in shares of Amrize Ltd (NYSE:AMRZ) by 12.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 165,401 shares of the company’s stock after acquiring an additional 18,637 shares during the quarter. Kestra Advisory Services LLC’s holdings in Amrize were worth $6,184,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Rakuten Investment Management Inc. bought a new stake in Amrize during the 3rd quarter worth approximately $1,220,000. Bank Julius Baer & Co. Ltd Zurich lifted its holdings in Amrize by 8.8% during the third quarter. Bank Julius Baer & Co. Ltd Zurich now owns 2,102,975 shares of the company’s stock valued at $78,985,000 after purchasing an additional 170,551 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Amrize in the third quarter worth approximately $49,000. MGO One Seven LLC boosted its position in shares of Amrize by 21.3% in the third quarter. MGO One Seven LLC now owns 24,104 shares of the company’s stock worth $901,000 after purchasing an additional 4,228 shares during the period. Finally, CHICAGO TRUST Co NA boosted its position in shares of Amrize by 90.8% in the third quarter. CHICAGO TRUST Co NA now owns 25,638 shares of the company’s stock worth $959,000 after purchasing an additional 12,202 shares during the period.

Analyst Upgrades and Downgrades

AMRZ has been the topic of several recent analyst reports. Bank of America downgraded shares of Amrize from a “neutral” rating to an “underperform” rating and decreased their price objective for the company from $50.00 to $40.00 in a research report on Wednesday, September 2nd. DA Davidson lifted their target price on shares of Amrize from $40.00 to $43.00 and gave the company a “neutral” rating in a research note on Friday, October 30th. Longbow Research began coverage on shares of Amrize in a report on Monday, October 12th. They issued a “buy” rating for the company. JPMorgan Chase & Co. cut their price target on Amrize from $52.00 to $48.00 and set a “neutral” rating for the company in a research note on Tuesday, October 13th. Finally, Wells Fargo & Company cut their price target on Amrize from $40.00 to $39.00 and set an “equal weight” rating for the company in a research note on Friday, October 30th. Eight investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $47.65.

Insider Buying and Selling

In related news, CEO Jan Jenisch acquired 4,000 shares of the stock in a transaction dated Wednesday, September 2nd. The stock was acquired at an average cost of $42.50 per share, with a total value of $170,000.00. Following the purchase, the chief executive officer directly owned 519,000 shares of the company’s stock, valued at approximately $22,057,500. This trade represents a 0.78% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Jacques Sanche bought 4,150 shares of the company’s stock in a transaction dated Wednesday, August 26th. The stock was bought at an average price of $45.02 per share, with a total value of $186,833.00. Following the acquisition, the director owned 9,766 shares in the company, valued at approximately $439,665.32. This trade represents a 73.90% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders have acquired 34,155 shares of company stock worth $1,461,276. Company insiders own 0.54% of the company’s stock.

Amrize Price Performance

NYSE:AMRZ opened at $41.58 on Thursday. The company has a current ratio of 1.07, a quick ratio of 0.67 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $22.99 billion, a P/E ratio of 18.81, a P/E/G ratio of 1.64 and a beta of 0.04. Amrize Ltd has a 12 month low of $35.78 and a 12 month high of $65.94. The business’s 50-day moving average is $39.43 and its 200 day moving average is $50.12.

Amrize (NYSE:AMRZ) last released its quarterly earnings results on Wednesday, October 28th. The company reported $1.05 earnings per share for the quarter, meeting the consensus estimate of $1.05. Amrize had a return on equity of 10.02% and a net margin of 9.93%. The business had revenue of $3.77 billion during the quarter. During the same quarter in the prior year, the business earned $0.98 EPS. The business’s quarterly revenue was up 2.6% compared to the same quarter last year. On average, equities research analysts forecast that Amrize Ltd will post 2.30 earnings per share for the current fiscal year.

Amrize Dividend Announcement

The business also recently disclosed a dividend, which will be paid on Wednesday, November 18th. Shareholders of record on Tuesday, November 10th will be paid a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, November 10th. Amrize’s payout ratio is presently 4.98%.

About Amrize

Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets. The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects. Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim’s North American business.